Spinal Restoration, Inc. Closes $5 Million Round for FDA Submission
10/23/2012 6:56:00 AM
More...
|
Spinal Restoration, Inc. Completes Enrollment of the Phase III Study of the Biostat® System
7/11/2012 10:30:55 AM
More...
|
Spinal Restoration, Inc. Updates the Progress of the Biostat® System and Ongoing Phase III Clinical Study Following the CBS Sunday Morning Segment "A New Hope for Back Pain Sufferers?"
5/9/2012 10:27:00 AM
More...
|
Spinal Restoration, Inc. Receives Patent Allowance for the Biostat® System
8/23/2011 10:36:44 AM
More...
|
Two-Year Outcomes Reported from the FDA Regulated Pilot Study of the Spinal Restoration, Inc. Biostat(R) System
8/17/2011 8:26:31 AM
More...
|
Spinal Restoration, Inc. Initiates Patient Enrollment for Phase III Study of Company's Biostat(R) System
3/16/2010 10:21:09 AM
More...
|
Spinal Restoration, Inc. Reaches Agreement with FDA on the Special Protocol Assessment (SPA) for the Phase 3 Trial of the Biostat(R) System
12/15/2009 6:46:00 AM
More...
|
Spinal Restoration, Inc. Announces the Submission of the Investigational Device Exemption (IDE) Pilot Study Results for the Biostat(R) System
6/9/2009 9:07:41 AM
More...
|
Spinal Restoration, Inc. Completes Patient Enrollment in Its Pilot Study of the Biostat® Disc Augmentation System for the Treatment of Discogenic Low Back Pain
9/9/2008 8:52:30 AM
More...
|
Spinal Restoration, Inc. Receives FDA IDE Approval
5/13/2008 8:06:40 AM
More...
|
|